← Leaderboards
Andrew M McDonald
University Of Alabama At Birmingham
$1,995,936
Attributed
$3,039,331
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $736.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,039,331 · 3
By mechanism
UG1$1,391,193 · 1
K08$1,269,780 · 1
R21$378,358 · 1
Top collaborators
- Charles A. Leath3 shared
- Amitkumar N Mehta3 shared
- Erica Michelle Stringer-Reasor3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Eben L Rosenthal$10,844,750
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisQuality Of LifeSiteResearch PersonnelAreaPatient PopulationRadiationSuccessTrainingReportingBrainSurvivorshipPersonsBrain RegionMentorsMorbidity - Disease RateHigh RiskMalignant NeoplasmsScientistCancer TherapyCancer SurvivorCandidate Disease GeneCharacteristicsAdjuvant Therapy
Grant awards (10)
NCTN Deep South Research Consortium$450,954
UG1 · FY2025 · CA
NCTN Deep South Research Consortium$457,700
UG1 · FY2024 · CA
NCTN Deep South Research Consortium$482,539
UG1 · FY2023 · CA
Multimodal study of cognitive impairment following radiation therapy for locally advanced head and neck cancer$253,956
K08 · FY2023 · CA · contact PI
Multimodal study of cognitive impairment following radiation therapy for locally advanced head and neck cancer$253,956
K08 · FY2022 · CA · contact PI
A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer$170,087
R21 · FY2022 · CA · contact PI
Multimodal study of cognitive impairment following radiation therapy for locally advanced head and neck cancer$253,956
K08 · FY2021 · CA · contact PI
A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer$208,271
R21 · FY2021 · CA · contact PI
Multimodal study of cognitive impairment following radiation therapy for locally advanced head and neck cancer$253,956
K08 · FY2020 · CA · contact PI
Multimodal study of cognitive impairment following radiation therapy for locally advanced head and neck cancer$253,956
K08 · FY2019 · CA · contact PI